AAAAAA
Results: 26-50/849
Authors:
Mauser-Bunschoten, EP
van der Bom, JG
Bongers, M
Twijnstra, M
Roosendaal, G
Fischer, K
van den Berg, HM
Citation: Ep. Mauser-bunschoten et al., Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A, HAEMOPHILIA, 7(4), 2001, pp. 364-368
Authors:
Gensana, M
Altisent, C
Aznar, JA
Casana, P
Hernandez, F
Jorquera, JI
Magallon, M
Massot, M
Puig, L
Citation: M. Gensana et al., Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII, HAEMOPHILIA, 7(4), 2001, pp. 369-374
Authors:
Kallas, A
Talpsep, T
Citation: A. Kallas et T. Talpsep, von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients, HAEMOPHILIA, 7(4), 2001, pp. 375-380
Authors:
Theophilus, BDM
Enayat, MS
Williams, MD
Hill, FGH
Citation: Bdm. Theophilus et al., Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A, HAEMOPHILIA, 7(4), 2001, pp. 381-391
Authors:
Hacker, MR
Geraghty, S
Manco-Johnson, M
Citation: Mr. Hacker et al., Barriers to compliance with prophylaxis therapy in haemophilia, HAEMOPHILIA, 7(4), 2001, pp. 392-396
Authors:
Mauser-Bunschoten, EP
Hamers, MJ
De Roode, D
Terlingen-Van Baaren, G
De Kleijn, P
Bos, R
van den Berg, HM
Citation: Ep. Mauser-bunschoten et al., Improvement of patient education and information: development of a patient's information dossier, HAEMOPHILIA, 7(4), 2001, pp. 397-400
Authors:
Acquila, M
Bottini, F
Valetto, A
Caprino, D
Mori, PG
Bicocchi, MP
Citation: M. Acquila et al., A new strategy for prenatal diagnosis in a sporadic haemophilia B family, HAEMOPHILIA, 7(4), 2001, pp. 416-418
Authors:
Bauduer, F
Ducout, L
Bendriss, P
Falaises, B
Lavergne, JM
Citation: F. Bauduer et al., Mild haemophilia A discovered in a previously multi-operated 73-year-old man: characterization of a new mutation, HAEMOPHILIA, 7(4), 2001, pp. 419-421
Authors:
Mazzucconi, MG
Bizzoni, L
Giorgi, A
Morano, SG
Peraino, M
Russo, M
Alimena, G
Citation: Mg. Mazzucconi et al., Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone, HAEMOPHILIA, 7(4), 2001, pp. 422-427
Authors:
Godreuil, S
Navarro, R
Quittet, P
Landreau, L
Schved, JF
Biron-Andreani, C
Citation: S. Godreuil et al., Acquired haemophilia in the elderly is a severe disease: report of five new cases, HAEMOPHILIA, 7(4), 2001, pp. 428-432
Authors:
Billon, S
Blouch, MT
Escoffre-Barbe, M
Le Niger, C
Le Roux, AM
Abgrall, JF
Citation: S. Billon et al., A case of chronic myelomonocytic leukaemia and factor XI deficiency with acirculating anticoagulant, HAEMOPHILIA, 7(4), 2001, pp. 433-436
Authors:
Danusantoso, H
Heijnen, L
Citation: H. Danusantoso et L. Heijnen, Tai Chi Chuan for people with haemophilia, HAEMOPHILIA, 7(4), 2001, pp. 437-439
Authors:
Beeton, K
Citation: K. Beeton, Tai Chi Chuan for persons with haemophilia: commentary, HAEMOPHILIA, 7(4), 2001, pp. 437-437
Authors:
Barnes, C
Brewin, T
Ekert, H
Citation: C. Barnes et al., Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure: progress report, HAEMOPHILIA, 7(4), 2001, pp. 439-440
Authors:
Cohen, AJ
Kessler, CM
Ewenstein, BM
Citation: Aj. Cohen et al., Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America, HAEMOPHILIA, 7(3), 2001, pp. 235-241
Authors:
Yoshioka, A
Shima, M
Fukutake, K
Takamatsu, J
Shirahata, A
Citation: A. Yoshioka et al., Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan, HAEMOPHILIA, 7(3), 2001, pp. 242-249
Authors:
Josic, D
Kannicht, C
Loster, K
Pock, K
Iberer, G
Buchacher, A
Citation: D. Josic et al., Vitronectin in clotting factor IX concentrates, HAEMOPHILIA, 7(3), 2001, pp. 250-257
Authors:
Leissinger, C
Becton, D
Cornell, C
Gill, JC
Citation: C. Leissinger et al., High-dose DDAVP intranasal spray (Stimate((R))) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A, HAEMOPHILIA, 7(3), 2001, pp. 258-266
Authors:
Astermark, J
Berntorp, E
White, GC
Kroner, BL
Citation: J. Astermark et al., The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development, HAEMOPHILIA, 7(3), 2001, pp. 267-272
Authors:
Ghosh, K
Shetty, S
Kulkarni, B
Nair, S
Pawar, A
Khare, A
Baindur, S
Mohanty, D
Citation: K. Ghosh et al., Development of inhibitors in patients with haemophilia from India, HAEMOPHILIA, 7(3), 2001, pp. 273-278
Authors:
Ekert, H
Brewin, T
Boey, W
Davey, P
Tilden, D
Citation: H. Ekert et al., Cost-utility analysis of recombinant factor VIIa (NovoSeven((R))) in six children with long-standing inhibitors to factor VIII or IX, HAEMOPHILIA, 7(3), 2001, pp. 279-285
Authors:
Klukowska, A
Czyrny, Z
Laguna, P
Brzewski, M
Serafin-Krol, MA
Rokicka-Milewska, R
Citation: A. Klukowska et al., Correlation between clinical, radiological and ultrasonographical image ofknee joints in children with haemophilia, HAEMOPHILIA, 7(3), 2001, pp. 286-292
Authors:
Schoenmakers, MAGC
Gulmans, VAM
Helders, PJM
Van den Berg, HM
Citation: Magc. Schoenmakers et al., Motor performance and disability in Dutch children with haemophilia: a comparison with their healthy peers, HAEMOPHILIA, 7(3), 2001, pp. 293-298
Authors:
Soares, RPS
Chamone, DAF
Bydlowski, SP
Citation: Rps. Soares et al., Factor VIII gene inversions and polymorphisms in Brazilian patients with haemophilia A: carrier detection and prenatal diagnosis, HAEMOPHILIA, 7(3), 2001, pp. 299-305
Authors:
Klein, I
Andrikovics, H
Bors, A
Nemes, L
Tordai, A
Varadi, A
Citation: I. Klein et al., A haemophilia A and B molecular genetic diagnostic programme in Hungary: ahighly informative and cost-effective strategy, HAEMOPHILIA, 7(3), 2001, pp. 306-312